Bryant David Lim

CIK: 0001752888

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PRLD

Prelude Therapeutics Inc

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

PRLD
Prelude Therapeutics Inc
Feb 4, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
275K shares-
PRLD
Prelude Therapeutics Inc
Feb 4, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
200K shares-
PRLD
Prelude Therapeutics Inc
Dec 19, 2024
Purchase(P)
Direct
25K shares at avg. $0.91$23K

		Type	Shares	Price		Ownership
Feb 4, 2026	PRLD Prelude Therapeutics Inc	Award(A) Employee Stock Option (right to buy)	275,000	-	-	Direct
Feb 4, 2025	PRLD Prelude Therapeutics Inc	Award(A) Employee Stock Option (right to buy)	200,000	-	-	Direct
Dec 19, 2024	PRLD Prelude Therapeutics Inc	Purchase(P)	25,000	$0.91	$22,638	Direct

1-3 of 3 transactions

About Lim Bryant David

Lim Bryant David (SEC CIK 0001752888) files insider reports with the SEC as CLO, CFO, Corp Sec. of Prelude Therapeutics Inc (PRLD).

Signal8 holds 3 ownership filings by Lim Bryant David, all Form 4s, filed between Dec 20, 2024 and Feb 5, 2026. Those filings report 3 transactions, from Dec 19, 2024 to Feb 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lim Bryant David's filings is in WILMINGTON, DE.

Recent filings by Lim Bryant David

Feb 4, 2026: Grant or award of PRLD derivative securities (Form 4, code A).
Feb 4, 2025: Grant or award of PRLD derivative securities (Form 4, code A).
Dec 19, 2024: Open-market purchase of PRLD shares (Form 4, code P).

Other insiders filing for Prelude Therapeutics Inc (PRLD)

BAKER BROS. ADVISORS LP, Director
Dorton Katina, Director
Babler Martin, Director
Bonita David P, Director
Sandor Victor, Director
FRIEDMAN PAUL A, Director

How to read Form 4 transaction codes